BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

8.26
Delayed Data
As of Dec 14
 -0.33 / -3.84%
Today’s Change
4.25
Today|||52-Week Range
9.71
+68.23%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close8.59
Today’s open8.54
Day’s range8.18 - 8.75
Volume504,529
Average volume (3 months)628,917
Market cap$1.0B
Data as of 4:00pm ET, 12/14/2018

Growth & Valuation

Earnings growth (last year)-4.00%
Earnings growth (this year)-25.78%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-4.43%
P/E ratioNM
Price/Sales16.46
Price/Book10.81

Competitors

 Today’s
change
Today’s
% change
IFRXInflarx NV-0.70-2.51%
NTLAIntellia Therapeutic...-0.09-0.57%
CHRSCoherus BioSciences ...-0.25-2.51%
DCPHDeciphera Pharmaceut...+0.78+3.07%
Data as of 4:00pm ET, 12/14/2018

Financials

Next reporting dateFebruary 26, 2019
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$25.2M
Annual profit (last year)-$65.8M
Net profit margin-261.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts